What Is Kisspeptin-10 Studied For? Research Areas, Per the Literature

Short answer: what the published literature actually covers

The question "what is kisspeptin-10 used for" is answered here only as what kisspeptin-10 has been studied for. Kisspeptin-10 is a ten amino acid fragment of the kisspeptin peptide family that signals through the KISS1R receptor, a receptor sitting upstream of gonadotropin releasing hormone neurons. Most of the available literature summarised below is animal work or cell culture work, and the research questions span reproductive endocrinology, sperm biology, behavioural neuroscience, cancer cell signalling, cellular ageing and receptor pharmacology.

Kisspeptin-10 is not approved by the FDA as a medicine for any condition. This page is not guidance. This page is for educational purposes only and is not medical advice; consult a licensed physician for any question about health, diagnosis or treatment.

Related reading: the Kisspeptin-10 learn hub.

Research area map at a glance

Research area 1: luteinising hormone and testosterone release

The most consistently investigated question is whether kisspeptin-10 can trigger the reproductive hormone cascade. A 2012 animal study in pre-pubertal and post-pubertal male goats reported that kisspeptin-10 stimulated the release of luteinising hormone and testosterone, and the study compared responses across the two developmental stages (PMID 22694333). Researchers in that work framed kisspeptin-10 as a probe of the hypothalamic-pituitary-gonadal axis rather than as a treatment.

A related line of work asked whether kisspeptin acts only in the brain or also directly at the gonad. A 2014 study in rhesus monkeys examined intratesticular action of kisspeptin, testing whether the peptide produced effects at the level of the testis itself (PMID 23758287). Both of these are animal studies in non-human primates and livestock species, not clinical trials.

What this does not establish

Neither the goat study (PMID 22694333) nor the rhesus monkey study (PMID 23758287) tested human clinical endpoints such as fertility outcomes, symptom scores or long term safety. Extrapolation from hormone release in animals to human treatment is not supported by those papers.

Research area 2: semen characteristics and sperm function

Livestock reproduction research has examined kisspeptin as a tool for improving breeding metrics. A 2020 animal study in Ossimi rams reported that kisspeptin injection improved semen characteristics and sperm rheotaxis, the tendency of sperm to orient against fluid flow (PMID 31880370). The model was a farm species studied for breeding purposes, and the study did not evaluate human semen parameters.

Research area 3: sexual behaviour circuitry in rodents

Beyond hormones, researchers have asked whether kisspeptin signalling participates in behaviour. A 2016 animal study examined kisspeptin in the medial amygdala and sexual behaviour in male rats, placing the peptide within a brain region associated with socio-sexual processing rather than only within the hypothalamic hormone axis (PMID 27233219). This is rodent neuroscience; the paper reported behavioural and anatomical observations in rats and did not address human libido or sexual function outcomes.

Research area 4: metabolic state, leptin and fertility signalling

Kisspeptin neurons sit at a junction between energy status and reproduction. A 2014 animal study reported that leptin-responsive GABAergic neurons regulate fertility through pathways that result in reduced kisspeptinergic tone, which positions kisspeptin signalling downstream of metabolic cues rather than as an isolated switch (PMID 24760864). The experiments were conducted in laboratory animals using genetic and neuroanatomical approaches.

Research area 5: seasonal and photoperiodic reproduction

Seasonal breeders switch reproductive function on and off with day length. A 2006 animal study in hamsters reported that kisspeptin mediates the photoperiodic control of reproduction, implicating kisspeptin signalling in the pathway that translates light exposure into reproductive status (PMID 16950111). That work is frequently referenced as foundational comparative endocrinology and was performed in rodents, not in people.

Research area 6: veterinary reproductive pathology

Veterinary science has examined kisspeptin in disorders of the ovary. A 2018 veterinary publication addressed kisspeptin and bovine follicular cysts, a common cause of reproductive failure in dairy cattle (PMID 29631312). The relevance is to cattle herd fertility management as studied in that species, and the publication did not evaluate human ovarian conditions.

Research area 7: cancer cell signalling in vitro

KISS1 and its receptor were first characterised in the context of metastasis suppression, and later cell work has shown the signalling picture is more complex. A 2016 in vitro study using human breast cancer cells reported that KISS1R signalling promoted invadopodia formation through a beta-arrestin2 and ERK dependent mechanism (PMID 26721186). Invadopodia are structures associated with the ability of cells to degrade matrix and invade. This is cultured human cell line work, not an animal or clinical study, and it illustrates that receptor activation has context dependent consequences.

Research area 8: neuronal ageing, mitophagy and autophagy

A separate line of research has looked at kisspeptin outside reproduction entirely. A 2021 study reported that kisspeptin preserved mitochondrial function by inducing mitophagy and autophagy in the ageing rat brain hippocampus and in a human neuronal cell line, combining an animal model with an in vitro human cell model (PMID 32926943). Researchers framed the findings as mechanistic cell biology relating to ageing pathways. No cognitive or clinical outcomes in people were tested in that work.

Research area 9: receptor selectivity and off-target pharmacology

Selectivity matters when interpreting any kisspeptin result. A receptor pharmacology study reported that kisspeptin receptor ligands activated neuropeptide FF receptors, meaning that effects observed after administering such ligands cannot automatically be assigned to KISS1R alone (PMID 24900254). The work was conducted in receptor assay systems rather than in animals or people, and it is an important caveat for reading the rest of the literature.

Research area 10: engineered delivery systems in preclinical disease models

Peptide and vesicle engineering intersects with reproductive biology in recent preclinical work. A 2025 study described oral engineered extracellular vesicles built on an ion exchange strategy for multipronged management of Wilson's disease complicated with reproductive dysfunction (PMID 40673828). The relevance here is to delivery technology and to reproductive dysfunction as a disease endpoint in a preclinical setting, not to any established use of kisspeptin-10 itself in humans.

Where the evidence is thin, preclinical only or absent

Several uses that are commonly searched for are not supported by the verified literature summarised on this page.

• Human fertility treatment: the hormone release findings available here come from goats (PMID 22694333) and rhesus monkeys (PMID 23758287), not from human fertility trials.
• Libido or sexual function in people: the behavioural evidence cited here is a rat medial amygdala study (PMID 27233219), and no human behavioural trial appears in this citation set.
• Testosterone management in men: testosterone responses described here were measured in male goats (PMID 22694333) and testis-level effects in monkeys (PMID 23758287), which are animal endpoints.
• Cancer therapy: the breast cancer work cited here was cell culture signalling research, and it reported receptor-driven promotion of invadopodia rather than any therapeutic benefit (PMID 26721186).
• Brain ageing or cognition in people: the mitophagy findings came from ageing rat hippocampus and a human neuronal cell line (PMID 32926943), which are mechanistic models rather than clinical outcomes.

Safety and Adverse Events: What Studies Report

The verified papers summarised here were designed around mechanism, hormone measurement, breeding metrics, cell signalling and analytical detection, and they are not safety trials. No human adverse event profile can be drawn from them. The most directly safety-relevant observation in this set is pharmacological rather than clinical: researchers reported that kisspeptin receptor ligands also activated neuropeptide FF receptors in receptor assays, meaning off-target receptor engagement is a documented consideration (PMID 24900254). A second consideration comes from oncology cell biology, where KISS1R signalling promoted invadopodia formation in human breast cancer cells in vitro (PMID 26721186), a reminder that receptor activation is context dependent. Livestock and rodent studies such as the ram semen work (PMID 31880370) reported production and physiology endpoints in those species and do not substitute for human tolerability data.

Regulatory and status notes

Kisspeptin-10 appears in the research literature as an investigational peptide and, in sports science, as an analyte that testing laboratories have developed urine detection methods for using high-resolution mass spectrometry (PMID 38978171). Materials labelled for research use only are not medicines and are not evaluated for human administration.

Kisspeptin-10 is not approved by the FDA as a medicine for any condition. This page is not guidance. This page is for educational purposes only and is not medical advice; consult a licensed physician before making any health decision.

References

• Kisspeptin-10 stimulates the release of luteinizing hormone and testosterone in pre- and post-pubertal male goats (Animal Science Journal, 2012)
• Intratesticular action of kisspeptin in rhesus monkey (Macaca mulatta) (Andrologia, 2014)
• Kisspeptin injection improved the semen characteristics and sperm rheotaxis in Ossimi ram (Reproduction in Domestic Animals, 2020)
• Kisspeptin in the medial amygdala and sexual behavior in male rats (Neuroscience Letters, 2016)
• Leptin-responsive GABAergic neurons regulate fertility through pathways that result in reduced kisspeptinergic tone (The Journal of Neuroscience, 2014)
• Kisspeptin mediates the photoperiodic control of reproduction in hamsters (Current Biology, 2006)
• Kisspeptin and bovine follicular cysts (Veterinaria Italiana, 2018)
• KISS1R signaling promotes invadopodia formation in human breast cancer cell via beta-arrestin2/ERK (Cellular Signalling, 2016)
• Kisspeptin preserves mitochondrial function by inducing mitophagy and autophagy in aging rat brain hippocampus and human neuronal cell line (BBA Molecular Cell Research, 2021)
• Activation of Neuropeptide FF Receptors by Kisspeptin Receptor Ligands (ACS Medicinal Chemistry Letters, 2011)
• Investigating the detection of the novel doping-relevant peptide kisspeptin-10 in urine using liquid chromatography high-resolution mass spectrometry (Biomedical Chromatography, 2024)
• Oral Engineered Extracellular Vesicles Based on Ion Exchange Strategy for Multipronged Management of Wilson's Disease Complicated with Reproductive Dysfunction Therapy (Advanced Science, 2025)